Previous 10 | Next 10 |
ICON plc , (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at Evercore ISI 2nd Annual HealthCONx Conferen...
ICON plc , (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at Jefferies 2019 London Healthcare Conference...
Image source: The Motley Fool. ICON (NASDAQ: ICLR) Q3 2019 Earnings Call Oct 24, 2019 , 9:00 a.m. ET Operator Continue reading
ICON Public Limited Company (ICLR) Q3 2019 Earnings Conference Call October 24, 2019 9:00 a.m. ET Executives Steve Cutler - CEO Brendan Brennan - CFO Jonathan Curtain - VP, Corporate Finance and IR Andrew Wald - Barclays Analysts Elizabeth Anderson - Evercore ISI John K...
The following slide deck was published by ICON Public Limited Company in conjunction with their 2019 Q3 earnings Read more ...
Acquisition enhances ICON’s ability to offer customers hybrid trial solutions and site support services ICON plc , (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries, ...
Highlights Record net business wins in the quarter of $931 million; a book to bill of 1.31. Quarter 3 reported revenue of $710.4 million. This represents strong year on year growth of 8.5% or 9.5% on a constant currency basis. Adjusted earnings per share attributable to the Gr...
ICON plc , (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced that Dr. Steve Cutler, CEO and Mr. Brendan Brennan, CFO of ICON plc, will present at Baird’s 20...
ICON Public Limited Company (ICLR) Q2 2019 Earnings Conference Call July 25, 2019 10:00 AM ET Company Participants Jonathan Curtain - Vice President, Corporate Finance & Investor Relation Brendan Brennan - Chief Financial Officer Steve Cutler - Chief Executive Officer Conf...
The following slide deck was published by ICON Public Limited Company in conjunction with their 2019 Q2 earnings Read more ...
News, Short Squeeze, Breakout and More Instantly...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a number of leading business and industry awards recognising the company’s leadership position in the clinical research industry, in addi...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second quarter 2024 after the market closes on Wednesday, July 24, 2024. The company will hold a conference call and webcas...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET. Any changes to this event and links...